Reinsurance Group of America just printed a sharp short-side capitulation. Short interest dropped 31% in a single week. Yet the options market is pushing back.
RGA's short interest fell to 1.22% of free float as of August 11. That's down from roughly 1.78% a week prior. It marks the fastest weekly retreat since late July. The stock gained 3.6% over the same period, rising to $244.65.
This is a clean post-earnings unwind. RGA reported Q2 on August 6 and posted a +4.2% one-day move. Bears who held into the print appear to have closed out quickly. Short interest is now at its lowest level in the 30-day history of this data.
Borrow conditions remain completely unconstrained. Availability is effectively unlimited — 64.8 million shares are available to borrow against fewer than 805,000 actually borrowed. Cost to borrow sits at 0.45%, near the low end of its recent range. There is no friction on the short side at all.
That's what makes the options signal worth watching. The put/call ratio sits at 0.42, nearly 2.0 standard deviations above its 20-day mean of 0.19.
This is not a small drift. For most of July, RGA's PCR sat below 0.10 — reflecting almost no hedging demand. The ratio began climbing around August 7, the day after earnings, and has held elevated since. Noted in the prior coverage on August 7: the PCR was already ticking higher at that point. It has continued.
The divergence is clear. Shorts are covering. Options buyers are adding puts. Two groups, reading the same post-earnings tape, drawing opposite conclusions.
The analyst community has not wavered. JP Morgan raised its target to $293 from $286 on August 11, maintaining Overweight. Barclays raised to $290 from $278 on August 7. The consensus mean target stands at $266.89 — roughly 9% above the current price of $244.65.
Five of the last eight analyst actions since early July have been target raises. No downgrades. The institutional holder base is also stable, with BlackRock holding 10.4% and FMR at 8.9% as of July 31.
The ORTEX short score has dropped to 29.8 from 32.2 a week ago — confirming the reduced short-side pressure in the data.
The PCR at 0.42 stands roughly 2 standard deviations above the recent norm. Whether that put activity is protective hedging by longs who rode the earnings rally — or genuine directional bearishness — will likely clarify as the position matures. Next earnings are not due until November 5.
See the live data behind this article on ORTEX.
Open RGA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
